Incyte (INCY)Grimes & Co Wealth Management, LLC reduced its stake -1,951 shares
Grimes & Co Wealth Management, LLC reduced its stake in Incyte, per its Q2 2026 13F.
- 134K
- Shares reported · -1,951 vs prior quarter
- 0.33%
- Disclosed portfolio weight
- $15.2M
- Reported value
- Holdings as of
- Jun 30, 2026
- Filed
- Jul 17, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- May 18, 2026FDAFDA drug approval: Zynyz
- May 19, 2026InsiderDirector sold ~$1.42M of INCY shares in the open market
- May 26, 2026InsiderOfficer sold ~$200K of INCY shares in the open market
- Jun 4, 2026InsiderOfficer sold ~$264K of INCY shares in the open market
- Jul 15, 2026Insider · 13 days before resultsOfficer sold ~$3.19M of INCY shares in the open market
- Jul 16, 2026Insider · 2 peopleInsiders: 2 sales (~$341K)
What came next
- Jul 28, 2026Company filing · Form 8-K · ResultsReported its results
- Jul 31, 2026Insider · 2 peopleInsiders: 12 sales (~$6.9M)
- Aug 3, 2026InsiderOfficer sold ~$729K of INCY shares in the open market
- Aug 5, 2026Insider · 2 peopleInsiders: 2 sales (~$1.6M)
- Aug 12, 2026InsiderOfficer sold ~$1.3M of INCY shares in the open market
- Aug 19, 2026InsiderOfficer sold ~$1.36M of INCY shares in the open market
- Sep 15, 2026Insider · 1 personInsiders: 2 sales (~$2.8M)
- Sep 25, 2026FDAFDA drug approval: Atebrioz
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Incyte
For Incyte, OQRO holds 23 insider filings (SEC Form 4 or Form 144) and 14 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its INCY page.
How this filing works
Other disclosures at Incyte
- SEC Form 4Sep 17, 2026
- SEC Form 4Sep 17, 2026
- SEC Form 144Sep 15, 2026
- SEC Form 4Aug 20, 2026
- SEC Form 4Aug 14, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its INCY page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
